Development of the latest class of incretin-based therapeutics for diabetes and obesity has been heralded as a major step ...

Follicle-stimulating hormone (FSH), a glycoprotein secreted by gonadotroph cells of the anterior pituitary, is classically ...

Over the past two decades there have been tremendous advancements in the understanding of both the prevalence and the ...

The UK is facing a pharma exodus. Major pharmaceutical companies have withdrawn about £2 billion in proposed investment from ...

FACT: #COVID19 is NOT airborne”, declared a tweet from WHO in March, 2020. WHO did not officially accept until almost 2 years ...

The integration of Bruton tyrosine kinase (BTK) inhibitors into first-line treatment regimens, in combination with ...

As the US foreign assistance architecture faces unprecedented dismantling, lessons from past crises take on urgent significance. Our new analysis of COVID-19 donor funding1 reveals a profound ...

International outcomes in breast, cervical, and ovarian cancers highlight opportunities to improve health-care delivery for ...

Amid accelerating advances in artificial intelligence, the UK risks neglecting the biological foundations of natural ...

In the REC-CAGEFREE I trial by Chao Gao and colleagues,1 an open-label, randomised, non-inferiority trial comparing a drug-coated balloon (DCB) with a drug-eluting stent (DES) in patients with de novo ...

Endogenous Cushing's syndrome is a severe, potentially lethal, endocrine condition. It is well known for its pleomorphic ...

Obesity has now reached pandemic proportions.1,2 WHO coined the term globesity to characterise its relentless rise worldwide ...